← All stocks

UroGen Pharma Ltd.

URGN Net selling
CIK 0001668243 #1945 in the set updated 17 Sep 2026
Bought (120 mo)
$791.52K
out of their own pocket, the only kind of buying there is
Sold (120 mo)
$15.54M
$1.30M on a plan · $1.46M straight out of an exercise
Sold at will
$12.77M
31 of 94 sales
Net
−$14.74M
−$11.98M against sales at will

By person

17 insiders · 114 transactions
16.2×

Elizabeth Barrett holds 16.2 times base salary in stock. $13.90M of shares against $855.59K in salary for 2025.

Salary from the company's own proxy. The shares are what Elizabeth Barrett last reported holding, valued at $42.54, the price Ordinary Shares was last bought or sold at on the open market here, on 8 Sep 2026.

Insider
Role
Bought
Sold
Net
Holding
Worth
Change
ProQuest Investments IV, L.P. entity
10% owner
$8.50M (2)
−$8.50M
1,242,031
$52.84M
−14.4%
Schoenberg Mark
Chief Medical Officer
$67.38K (3)
$5.38M (49)
−$5.31M
67,849
$2.89M
+217.5%
Smith Jason Drew
General Counsel
$39.28K (1)
$725.47K (19) scheduled
−$686.19K
53,141
$2.26M
Mullennix Stephen
Chief Operating Officer
$203.44K (7) scheduled
−$203.44K
10,084
$428.97K
PFREUNDSCHUH PETER P.
Chief Financial Officer
$166.69K (11) scheduled
−$166.69K
10,405
$442.63K
+940.5%
Barrett Elizabeth A.
Chief Executive Officer
$645.25K (4)
$491.88K (3)
+$153.37K
326,691
$13.90M
Degnan Chris
Chief Financial Officer
$37.12K (1) scheduled
−$37.12K
2,280
$96.99K
Henderson Molly
Chief Financial Officer
$39.63K (1)
$33.63K (2) scheduled
+$5.99K
5,248
$223.25K
Nussbaum Ran
Director
4,381,054
$186.37M
+1.3%
Belldegrun Arie
Director
408,693
$17.39M
+257.8%
Cohen Fred E
Director
84,339
$3.59M
Kim Dong
Chief Financial Officer
37,753
$1.61M
+18.3%
Robinson James A. Jr.
Director
8,000
$340.32K
WEN LEANA
Director
2,000
$85.08K
Wildman Daniel George
Director
2,000
$85.08K
Holden Stuart
Director
2,000
$85.08K
BUTITTA CYNTHIA M
Director
2,000
$85.08K

No percentages here. These insiders hold more than one class of share between them, and the share count on file covers one of them rather than all. Dividing the two would compare different things.

Insider
Date
Role
Action
Shares
Price
Amount
Schoenberg Mark
20 Jan 2023
Chief Medical Officer
Exercised, kept
122,677
$5.00
$613.39K
Nussbaum Ran
21 Oct 2022
Director
Exercised, kept indirect
47,999
$5.94
$285.11K
Belldegrun Arie
14 Sep 2022
Director
Exercised, kept
160,000
$5.00
$800.00K
Belldegrun Arie
31 Aug 2022
Director
Exercised, kept
3,241
$5.00
$16.21K
Nussbaum Ran
16 Jun 2022
Director
Exercised, kept indirect
2,211
$5.00
$11.06K
Nussbaum Ran
6 Jun 2022
Director
Exercised, kept indirect
1,030
$5.00
$5.15K
Nussbaum Ran
25 Mar 2021
Director
Exercised, kept indirect
2,211
$5.00
$11.06K
Nussbaum Ran
24 Mar 2021
Director
Exercised, kept indirect
1,030
$5.00
$5.15K
Belldegrun Arie
24 Mar 2021
Director
Exercised, kept
3,241
$5.00
$16.21K
Belldegrun Arie
27 Mar 2019
Director
Exercised, kept
128,000
$4.02
$514.56K
Cohen Fred E
6 Feb 2019
Director
Exercised, kept
15,000
$16.99
$254.85K

What was left out

Form 4 filings counted 195
Amendments (4/A) skipped 12
Filings about a different issuer 0
Unreadable filings 0
Joint filings 1
Sales on a Rule 10b5-1 plan 4
Sales straight out of an exercise 59
Sales at will 31
Transactions with no price 0
Shares from compensation/vesting 1,174,051
Sales filed before the plan box existed 17
History held since 29 Nov 2017